Araf, arabinofuranose; 2 DE, 2 dimensional electrophoresis; DEAE, diethylaminoehtyl; ESI-MS, electrospray ionization-mass spectrometry; ethambutol, Emb; GC, gas chromatography; HPAEC, high pH anion exchange chromatography; HSQC, heteronuclear single quantum correlation spectroscopy; IEF, isoelectricfocussing; LepLAM, derived from in vivo grown M. leprae is apparently simpler in its arabinan architecture with a high degree of exposed, non-mannose capped termini. CSU20, an ethambutol resistant clinical isolate, on the other hand makes a vastly heterogeneous population of LAM ranging from rather small and non-mannose capped, to full length and fully capped variants. LepLAM and CSU20LAM contain a higher level of succinylation than RvLAM which, in the context of truncated or less elaborated arabinan, may contribute to selective recognition by T cells. LAM from all species could be resolved into discrete forms by isoelectric focusing based apparently on their arabinan heterogeneity. In the light of our current and more recent findings, we reason that all immunobiological data should be cautiously interpreted and the actual LAM variants that may be present in vivo during infection and pathogenesis need to be taken into consideration.
INTRODUCTION
Substantial progress in leprosy control through multi-drug therapy (MDT) over the last two decades has led to a dramatic decline in prevalence from 10-12 million cases in the early 1980s to 534,000 today, as reported by 110 countries (1) . However, the current prevalence of 3.4 cases per 10,000 populations in the top endemic countries at the beginning of 2003 still exceeds the targeted elimination (1 per 10,000) of leprosy as a public health problem by the year 2000, as declared by the World Health Organization in 1991. In reality, the significance of leprosy as a disease has been undermined by the resurgence of tuberculosis in the late 1990s which directed much of the focus of mycobacterial research away from M. leprae to its close relative, the tubercle bacillus. M. leprae is unique in that it is non-cultivable in the laboratory with an exceptionally slow growth rate, perhaps the longest doubling time of all bacteria. The bacillus can only be isolated from a host, the nine-banded armadillo or humans, and by cultivation in mouse foot-pad (2) . Furthermore, leprosy is manifested as a spectrum of disease states depending on the responsiveness or unresponsiveness of various components in the host cellular immune system (3). It is therefore important to identify specific molecular determinants of M. leprae that would modulate the host immune response by dictating the molecular nature of host-pathogen interactions, the spectrum of cytokines induced and importantly, the T cell response elicited.
Unlike the more restricted expression of species-and/or strain-specific surface glycolipids, the cell wall associated lipoarabinomannan (LAM) and its related lipomannan (LM) are potent immunomodulators commonly found in all Mycobacterium spp. investigated to date. One of the more significant recent immunobiological finding is the firm identification of LAM from M. leprae (LepLAM), and not that from M. tuberculosis H37Rv (RvLAM), as the specific non-peptide antigens recognized by CD1b and CD1c restricted ab + CD4 -CD8 -double negative T cell lines derived from the skin lesion of a leprosy patient (4, 5) . The CD1 protein family has been proposed to comprise a distinct lineage of antigen presenting molecules involved specifically in the acquisition of cell mediated immunity to persistent intracellular pathogens (6) . Notably, the binding site in CD1 is hydrophobic and flexibly accommodates a variety of anchoring hydrocarbon chains while exposing the diverse polar moieties of the presented lipid antigens in a region accessible for recognition by T cell receptors. The T cell specificity demonstrated against LepLAM over RvLAM therefore indicates a significant structural difference between the two LAM and confers on LepLAM an antigenic role in mediating leprosy specific immunopathological responses.
LepLAM could be found in copious amounts in M. leprae (7) in comparison to M. tuberculosis.
Nevertheless, due to the problems in obtaining M. leprae source material for experimental studies, very little is currently known of its fine structure in contrast to the large body of work investigating LAM from the slow growing laboratory strains of M. tuberculosis and M. bovis BCG, as well as the fast growing M.
smegmatis, M. chelonae and M. kansasii (reviewed in (8, 9) . Stemming from these studies, the salient and common structural features of the extremely heterogeneous LAM are now relatively well established ( Fig.   1 ) although many of the fine details on the arabinan and mannan framework remain poorly understood.
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Structural variants of arabinans in LAM 4 the many known or implicated charged substituents on the arabinomannan has inevitably led to a perceivable emphasis on the non-reducing terminal capping functions which has been accorded a myriad of receptor binding and immunomodulatory roles. In contrast, no particular function has as yet been attributed to the characteristic terminal arabinan motifs, in which the degree of branching off the linear Arab1AE2Araa1AE[5Araa1AE] n chains to produce the branched Ara 6 termini, Arab1AE2Araa1AE5(Arab1AE 2Araa1AE3)Araa1AE5Araa1AE , is probably as important in determining the spatial conformation and density of the cap and hence its biological attributes.
The anti-tuberculosis drug, ethambutol (Emb) for example, could inhibit complete elaboration of the arabinan and consequently abolish its mannose capping functions in LAM from an Emb susceptible laboratory strain of M. tuberculosis at sub-minimal inhibitory concentration. Importantly, LAM from an Emb resistant M. tuberculosis clinical isolate (CSU19) was shown (10) to be more heterogeneous in the spread of size, ranging from full size to severely truncated, and have a significantly higher proportion of noncapped arabinan termini than RvLAM but retaining similar relative abundance of linear and branched arabinan termini. These and earlier studies demonstrated that the degree and chemical nature of capping functions on LAM is strain specific and dependent on the relative activities of the gene products involved in the biosynthesis of the arabinan which could be further affected by Emb. It also indicates that biological relevance of the capping function should be considered in the context of the underlying arabinan motifs.
Like LAM from M. tuberculosis, M. bovis BCG and M. avium, LepLAM is known to carry mannose caps but apparently at a very low level (11) . As no detailed structural studies have ever been performed, it is unclear if its overall arabinan and mannan structural framework bear any semblance to those of better characterized LAM such as RvLAM, especially in the light of the comparatively smaller genome of M.
leprae due to massive gene deletion and decay (12, 13) . It is likely that one or more of the complement of glycosyltransferases in M. leprae and other gene products involved in the synthesis of LAM, may be absent or non-functional.
Based on revised sample preparation protocols for better conservation of sample materials, we were able to accumulate milligram quantities of pure LepLAM to enable a thorough structural study. We show in this work that LepLAM maintains most structural attributes of RvLAM but encapsulated within a simpler form. The low degree of mannose capping is paralleled by an overall smaller arabinan which echoes the concept of reductive evolution for an obligate intracellular mycobacterium. Similar to our previous findings, LAM from another Emb resistant M. tuberculosis clinical isolate, CSU20 (CSU20LAM), was likewise found here to be drastically altered both by size and by reduction in the degree of mannose capping in comparison to the RvLAM. Rather unexpectedly, CD1 restricted T cell clones responsive to LepLAM and not RvLAM was found to be equally responsive to CSU20LAM. This is the first evidence that differential cell mediated immunopathological response could be elicited by LAM differing not in the identity of the capping function but the overall arabinan framework. CSU20LAM from a clinical isolate is shown here to be more akin to LepLAM than RvLAM in both structural features and T cell immunogenicity.
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EXPERIMENTAL PROCEDURES
Chemical reagents -All chemical reagents were of the highest grade from Sigma/Aldrich (Milwaukee, WI) unless otherwise specified. Milli-Q ® water was used for all chemical reactions.
Growth conditions of M. tuberculosis H37Rv and CSU20 -M. tuberculosis CSU20 is a clinical strain isolated from a patient in Korea. The MIC (minimal inhibitory concentration) values of CSU20 for Emb, cycloserine and pyrazinamide were 17, 60 and 50 mg/ml respectively. Frozen stocks of the strains were plated on 7H11 agar plates (Difco) with oleic acid/albumin/dextrose/catalase enrichment supplement for 3
weeks. Early colonies were picked and transferred to 5 ml of glycerol-alanine salts (GAS) broth for two weeks at 37°C on a shaker. Large-scale cultures were initiated by using 1 ml of broth from the starter cultures to inoculate 50 ml of fresh media. After seven days at 37 o C, 1 ml of the inoculated culture was transferred to 400 ml of broth at 37 o C for two weeks, then following the same procedure the culture was upscaled to a litre and grown until late log phase and harvested. About 8-10 g of cells were obtained from 2 litres of culture. M. tuberculosis H37Rv was used as our reference standard.
Extraction of LAM/LM/PIMs from M. tuberculosis H37Rv and CSU20
-Wet cells (~10g) were delipidated with chloroform:methanol:water (10:10:3) for two hours (x2) at room temperature and dried.
The dried biomass was suspended in breaking buffer containing protease inhibitor cocktail (pepstatin A, phenylmethylsulfonyl fluoride (PMSF), leupeptine), DNAse, and RNAse in PBS and disrupted mechanically using a French Press. Triton X-114 (Sigma/Aldrich) was added to the lysed cells to a final concentration of 8% (v/v) and, after cooling on ice, the solution was mixed at 4°C overnight. The cell wall was removed by centrifugation at 27,000 x g for 1 hour at 4°C, and the supernatant was incubated at 37°C to induce biphasic separation (14) . The upper aqueous layer was mixed with the cellular debris and re-extracted as described above. The detergent layers were combined and the lipoglycans precipitated by the addition of 9 volumes of cold ethanol (95%, -20°C). The precipitate was collected and treated with Proteinase K for 2 h at 60°C. The solution was dialyzed and lyophilized for further analysis.
Extraction of LAM/LM/PIMs from M. leprae -M. leprae was purified from nonirradiated armadillo livers by the Draper protocol (15) . Pure wet cells (approximately 500 mg, obtained from 250 g of infected armadillo liver) were suspended in 2.5 ml PBS and disrupted mechanically using a probe sonicator (W-385 Heat Systems-Ultrasonic) to achieve over 90% breakage of cells. The suspension after cell breakage was centrifuged at 27,000 x g for 1 h at 4°C. The cell pellet was re-suspended in PBS and centrifuged as before. The combined supernatants from both centrifugations containing both cytosol and membrane were then centrifuged at 100,000 x g for 2 h. The resulting pellet, representing the membrane fraction of M. leprae, was re-suspended in PBS containing Triton X-114 (4% by volume), mixed well at 4°C, placed at 37°C to induce phase separation and treated with ethanol as described above. The ethanol precipitate was collected, dried, and partitioned between phenol and water (16) . The aqueous layer from the phenol partition contained the majority of cellular LAM and LM. It was evaporated to dryness and was the basis for further purification steps. used to monitor the elution profile of the fractions containing LAM and LM, which were then pooled and dialyzed at 37°C without detergent followed by water for several days. LAM /LM fractions recovered were re-analyzed by SDS-PAGE to check for purity prior to detailed analysis. Sample concentrations were maintained at 2 mg in 10 ml of sample buffer. Immunoblotting with mAb CS-35 and CS-40 were performed essentially as described (17 
Digestion with endoarabinanase and subsequent analyses -Preparation of endoarabinanase
Cellulomonas gelida have been described (19) . To ensure complete digestion of LAMs, the reaction mixture was incubated overnight and aliquots were withdrawn and analyzed by SDS-PAGE to ensure production of the mannan core as gauged by its electrophoretic mobility compared with LM. The digestion products that contained both mannan core and the released oligoarabinosides were analyzed directly by Dionex Analytical HPAEC performed on a Dionex LC System fitted with a Dionex Carbopac PA-1 column.
The oligoarabinosides were detected with a pulse-amperometric detector (PAD-II) (Dionex, Sunnyvale, CA). For a preparative scale, CSU20LAM (a total of 4 mg) in 2x2 mg aliquots were taken in 100 ml of water and digested with 50 ml of enzyme for 4h, after which fresh 30 ml of enzyme was added and digestion continued for another 4 h. The digestion mixture was applied to a Biogel-P4 column at 50°C
(1000mm x 15mm, flow rate 10 ml/h). Digestion with a-mannosidase -Digestion with a-1,2,3,6 mannosidase (Prozyme, San Leandro, CA), was carried out in sodium phosphate buffer (150 mM, pH 7.0) initially for 10 h at 37°C using 1 ml of the enzyme per 50 µg of LAM. Aliquots were withdrawn and analyzed by Dionex HPAEC. To ensure complete digestion, a further 1 ml of the enzyme was added and the enzymatic digestion was continued for a further 16 h. The digestion was terminated by denaturing the enzyme.
Monosaccharide, fatty acids, and succinate composition-Samples were hydrolyzed with 2M TFA, converted to alditol acetates and analyzed by GC using scyllo-inositol as internal standard (20) . GC of the alditol acetates were performed on a Hewlett Packard Gas Chromatography Model 5890 fitted with a SP 2380 column (30m x 0.25 mm id) at an initial temperature of 50°C for 1 min, increasing to 170°C by 
CD1-restricted T-cell assays-CD1b-restricted T-cell lines derived from a skin biopsy of a cutaneous
lesion of a leprosy patient were co-cultured with antigen presenting cells pre-incubated with RvLAM, LepLAM and CSU20 LAM as described (4). T-cell proliferation was measured by incorporation of [ (Table I) . Table I ). Resonances of the overlapping anomeric regions could be better assigned via the well-resolved 2D 1 H-
RESULTS
Extraction and fractionation of LAM
Distinctive structural features of LepLAM by NMR analyses -
13
C HSQC experiment and by referring to a body of published NMR data on the structure of LAM (22, 24, 25) and its endoarabinanase generated fragments (26) . The glycosyl residue composition by NMR (Fig. 4) and the peak volumes are summarized in Table II the spectrum. In particular, there were noteworthy differences in the spectra of the LepLAM (Fig. 4A ) and CSU20LAM ( Fig. 4C ) in comparison to that of RvLAM (Fig. 4B) .
Based on the literature (22, (26) (27) (28) , evidence for the presence of mannose-capping on LepLAM was sought from the (Table II) . Although the degree of mannose capping cannot be unambiguously extrapolated from NMR due to strong overlapping of 2-a-Manp and 2,6-a-Manp resonances, our previous studies by linkage analyses (11) agreed with the results obtained from the HSQC spectra. Overlapping anomeric carbons at d104.8 correlated to protons at d5.08 and was assigned to t-a-Manp belonging to both the mannan core and the mannose caps. These cross peaks were less prominent in the LepLAM spectrum. Multiple distinct spin systems were observed centered between d110.4-d109.5 ppm correlating with protons between d5.20-d5.10. These were attributed to the 5-a-Araf and 3,5-a-Araf, which showed a marked complexity in RvLAM but yielded a much simpler spectra for LepLAM, indicating that the overall arabinan is simpler (Fig. 4 A, B) . Two well-separated spin systems were identified for 2-a-Araf (cross peaks for C-2 were detected at d88.7 and d88. (26, 30) as has been described to be a common constituent of all M. tuberculosis LAMs, were clearly absent in the LepLAM spectrum. The HSQC spectrum also revealed two distinct sets of carbons at d33.5 and d34.5 with protons centered at d2.67 and d2.5 (data not shown). These were attributed to the two methylene groups of the succinyl derivatives according to Delmas et al., (22) , although these were better resolved than reported.
Distinctive structural features of CSU20LAM by NMR analysis -NMR analyses of a heterogeneous population of CSU20LAM (Fig. 4C) showed no marked discrepancy with the spectrum of the RvLAM and other published spectra from M. bovis, BCG (25), M. chelonae, M. kansasii (27, 28) and thus indicate that the overall branching pattern and mannose capping were fairly similar throughout (Fig. 4B) . The presence of 5-MTX in CSU20LAM has already been shown in our earlier work (26) . However, unlike RvLAM, during the course of the purification by size exclusion chromatography, a subpopulation of LAM shorter in size (by SDS-PAGE) was also isolated from this strain. In order to examine if the diminution in length was due to shorter arabinan (i.e. decrease in 5-a-Araf) or lack of mannose capping (i.e. increase in t-Araf) as seen by guest on November 17, 2017
http://www.jbc.org/
Downloaded from
Structural variants of arabinans in LAM
12
in a previous clinical isolate (10), the 'truncated' or 'short' CSU20LAM was also analyzed by NMR for
comparison (results not shown). It was reasoned that if most of the non-reducing termini in CSU20LAM
were substituted with Manp, the vast majority of t-b-Araf will be substituted and thus appear as 5-b-Araf.
Quantitation of 5-Araf by methylation analysis could be misleading due to the presence of 5-a-Araf. In the NMR spectra, there is a perfect overlap in the anomeric signals of t-b-Araf and 5-b-Araf, and hence they cannot be distinguished in this region. However, due to the substitution of the mannose caps on the 5-OH, there is a significant shift for the C-5 of the b-Araf. Comparing the HSQC spectrum of 'normal' CSU20LAM against that defined as 'short' structures showed that almost all the anomeric resonances were comparable (data not included). The only noticeable differences were in the intensities of the peaks belonging to Manp residues. In 'normal' CSU20LAM, there were more 2-a-Manp and t-a-Manp from the caps than from the core. In contrast, in the anomeric region of 'short' LAM, 2-a-Manp and 2,6-a-Manp were found to afford approximately the same peak intensity as the t-aMan p from core and from caps.
From the same HSQC spectra, detailed analyses of the hydroxymethylene region showed that both LAMs had 5b-Araf (cross peaks at d71 ppm) but the intensity ratio of C5 of 5-b-Ara f :t-b-Ara f (two sets of cross peaks centered at d71 and d66 ppm) was higher for 'normal' CSU20LAM than for 'short' LAM, indicating that 'short' LAM had more (two fold) free, non-capped, non-reducing terminal b-Ara f . In summary, the data from 1 H- 13 C-HSQC spectra provided evidence that 'short' LAM contained less a-Man p cap units, but the underlying arabinan structure was similar to that of 'normal' LAM, i.e. with a similar degree of branching.
Endoarabinanase resistant core of CSU20LAM -In order to examine the internal regions of the arabinan built on the mannan core, CSU20LAM was subjected to exhaustive digestion with endogenous arabinanase. After four consecutive digestions, a core was obtained that gave a diffused band on SDS-PAGE and was slightly larger than LM (results not shown). 2D-NMR analysis of the core ( prior to digestion were clearly absent (Table II) , indicating that the non-reducing termini were removed.
The cross peak at d5.25 ppm was new, and was attributed to terminal a-Araf, which would arise from termination of the internal 5-a-Araf (d5.18 ppm) chain not due to b-Araf capping but trimming by the endoarabinanase. The cross peak of carbon at d101 ppm with proton at d5.2 ppm corresponded to 2,6-aManp, whereas t-a-Manp centered at d104.8 ppm and d5.17 ppm. Due to the saturation of the water peak, which overlapped with 6-a-Manp, cross peak for this residue was not visible in this experiment. The NMR results were corroborated by HPAEC analysis, as no Ara 2 , Ara 4 and Ara 6 were produced when the core was repeatedly digested with the enzyme.
Interestingly, the 1 H, 13 C-HSQC NMR spectrum also revealed two distinct sets of carbons, with four cross peaks at d32.5, d34.0, d36.1 and d37.7 correlating with protons at d2.72 and d2.65, d2.9 and d2.8.
These were attributed to the nonequivalent methylene groups of the succinyl derivatives. Because these (11) nonetheless supported the presence of di-and tri-mannose caps, albeit at low abundance. As for CSU20LAM, the data obtained was indicative of its close resemblance to another Emb-resistant clinical isolates, CSU19, which we previously characterized (10) by mapping its nonreducing terminal arabinan motifs. To determine if the underlying a5-arabinan chains also terminate in either one of the two well defined motifs, namely a branched Ara 6 or a linear Ara 4 , like all other LAMs examined to date (Fig. 1) , intact LepLAM, RvLAM and CSU20LAM were subjected to endoarabinanase digestion and the resulting products were mapped directly by HPAEC and, after Bio-Gel P6 clean up, followed by MS analysis.
As documented previously (10), mannose-capped RvLAM yielded predominantly Ara 2 , Man 2 Ara 4 and Man 4 Ara 6 as the major products, since a dimannosyl cap is most commonly found on each b-AraAE2-aAraAE terminus. Using RvLAM as a standard reference, the HPAEC profile of the endoarabinanase digestion products gave the aforementioned three major peaks which were subsequently converted to Ara 2 , Ara 4 and Ara 6 upon further a-mannosidase digestion to remove the caps (Fig. 6A) A drastically different profile was afforded by LepLAM in which the spectrum ( showed positive reactions to LAM albeit differentially (Fig. 9) . In contrast, LM was completely negative and interestingly, some sera reacted with the isolated PIMs. That the leprosy patients have high titre antibodies to LepLAM could be due to the fact that LepLAM is secreted or shed from the bacilli during the course of infection and is thereby readily recognized by the host. In fact, the presence of significant amounts of LepLAM in liver homogenate (supernatant obtained after the bacilli have been sedimented during the processing of M. leprae) has been demonstrated (results not shown).
Reactivity against sera indicated that LepLAM presents B-cell epitopes probably through the exposed arabinan. It is interesting to note that CD1b-restricted T cell lines derived from a skin biopsy of a cutaneous lesion of a leprosy patient has been shown to be reactive against the presented LepLAM. In the light of current findings in which CSU20LAM was demonstrated to be extremely heterogeneous and to some extent resembles LepLAM in containing populations of short and/or under-capped LAM, its reactivity against the leprosy derived CD1-restricted T cell clones were tested. The results showed that T cell clones LDN4 and LCD4, when treated with different concentrations of RvLAM, LepLAM and CSU20LAM, proliferated preferentially in response to LepLAM and CSU20LAM (Fig 10) . Proliferation against LepLAM is of no surprise and simply acted as positive control. Failure to recognize RvLAM argues that certain specificity was maintained against the presented non-lipid epitope. From the same rationale, recognition of CSU20LAM indicated that it is more comparable to LepLAM than RvLAM. That two and not just one independent CD1-restricted T cell clones gave similar discriminating specificity suggested that the shared characteristic is immunodominant which could not be ascribed simply to presence or absence of mannose cap. Thus, for the first time, an immunogenic trait of LAM has been attributed to not the capping or fatty acyl functions but possibly, the underlying arabinan constructs.
Additional isoforms in LepLAM and CSU20LAM -1D SDS-PAGE coupled with silver-PAS staining or
Western blot with anti-LAM monoclonal antibodies have been useful in assessing the heterogeneity of LAM in size which typically gives broad diffuse band. Interestingly, if SDS-PAGE analysis was preceded by a first dimensional IEF separation, both LepLAM and CSU20LAM, as well as RvLAM, could be similarly resolved into several discrete isoforms equilibrating at different pH instead of a mere horizontal spread (Fig. 11A) . Pre-fractionation into populations differing in the number of fatty acyl functions by hydrophobic interaction column chromatography did not alter the IEF blueprint as each of the pooled fractions gave the same number of isoforms across the 2DE. The data thus indicated that each LAM isoforms on the 2DE gel not only carried the same spread in size but also similar fatty acid composition and all contained the hexaarabinofuranoside Ara 6 motifs (18), demonstrated as positive reactivity against the monoclonal antibody CS-35 (data not shown). Focusing on CSU20LAM, treatment with amannosidase or removal of the caps with a-(1AE2)-mannosidase did not collapse the isoforms except some size shifting (Fig 11B, top panel) . However, as the arabinan was trimmed away by endoarabinanase digestion, the resulting mannan core could still be resolved into isoforms with more trailing of the bands and leaning towards lower pH (Fig. 11B, second panel) . LM, on the other hand ( . There is also evidence suggesting that the mannose-capped RvLAM is generally less effective in stimulating macrophages than the non-capped LAM which may owe its potency to unusual inositol phosphate capping or even the exposed arabinan ((27) as reviewed in (9,31)). Schlesinger et al. noted differences in the level of uptake between ManLAMs isolated from virulent or attenuated strains of M. tuberculosis (34, 35) . Moreover, it has been shown that certain CD1b and CD1c-restricted T-cells recognize LAM and PIMs specifically, and one cell line BDN2e was able to distinguish between RvLAM and LepLAM, suggesting subtle structural differences (4, 5) .
Overall then, the body of evidence implicating LAM in modulating immune response such as that manifested by macrophage cytokine induction is compelling. However, despite many of the structural studies emerging from this laboratory and many others (reviewed in (8) (36, 37) and the observation that with a dysfunctional EmbC, (a protein identified as a transmembrane arabinosyltransferase that seemed to add the Araf residues to the pre-existing 2 to 3 Araf residues in LM), nonpathogenic M. smegmatis is unable to synthesize LAM (38) . In M. tuberculosis, the EmbC has proven to be essential (Parish and Chatterjee, unpublished work). These studies could not however be extended to address the biological roles of the respective structural motifs of LAM, in particular the arabinan.
The specific recognition of LepLAM by the sera of leprosy patients and in a CD1-restricted manner by sonicates were electrophoresed and PAS staining was applied immediately following fixation to enhance the appearance of LAM, LM and PIMs. Table II . in serum 'a'). LM was consistently negative ('b-g'), and PIMs were faintly positive for only sera 'a' and 'h'. Sera 'a,b,d,g' and h were from lepromatous (LL) forms of leprosy and sera c,e, and f were from borderline lepromatous (BL) patients. by guest on November 17, 2017 
